| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.085 | 0.3 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.3 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |